Market research
19KA.F CorMedix Inc
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 523M
- P/E ratio
- 3.59
- Analyst target
- 21.25
- Dividend yield
- Not available
- Beta
- 1.5
Community
Investor discussion
1 comment
Sign in to join the 19KA.F discussion.
5 years, 5 months ago
CorMedix Inc is currently in a long term downtrend where the price is trading 21.0% below its 200 day moving average.
From a valuation standpoint, the stock is 12.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1149.8.
CorMedix Inc's total revenue rose by 124.9% to $56K since the same quarter in the previous year.
Its net income has dropped by 14.8% to $-6M since the same quarter in the previous year.
Finally, its free cash flow fell by 54.3% to $-6M since the same quarter in the previous year.
Based on the above factors, CorMedix Inc gets an overall score of 2/5.